Those companies receiving warning letters are Boehringer Ingelheim Roxane Inc., Columbus, Ohio; Cody Laboratories Inc., Cody, Wyoming; Glenmark Pharmaceuticals Inc., Mahwah, New Jersey; Lannett Company Inc., Philadelphia, Pennsylvania; Lehigh Valley Technologies Inc., Allentown, Pennsylvania; Mallinckrodt Inc. Pharmaceuticals Group, St. Louis, Missouri; Physicians Total Care Inc., Tulsa, Oklahoma; Roxane Laboratories Inc., Columbus, Ohio; and Xanodyne Pharmaceuticals Inc., Newport, Kentucky. The FDA ordered nine companies to stop selling unapproved drugs marketed for pain relief. "Doctors and patients are often unaware that not all drugs on the market are backed by FDA approval. -- Seeking to remove unapproved drugs from the marketplace, the Food and Drug Administration on Tuesday ordered nine companies to stop manufacturing narcotics whose therapeutic claims have not been proved. Those who find they are taking unapproved drugs should see their health care professionals for treatment options.